PARTNER: randomised, phase 2/3 trial evaluating safety & efficacy of adding olaparib to platinum-based neoadjuvant chemotherapy in triple negative and/or germline BRCA mutated breast cancer patients
Authors
Abraham, JVallier, L
Qian, W
Machin, A
Grybowicz, L
Thomas, S
Weiss, M
Harvey, C
McAdam, K
Hughes-Davies, L
Roberts, A
Roylance, R
Copson, E
Pinilla, K
Armstrong, Anne C
Provenzano, E
Tischkowitz, M
McMurtry, E
Earl, H
Affiliation
Dept of oncology, The Christie NHS FT, ManchesterIssue Date
2018